Objectives

After participating in this educational activity, attendees should be able to:
1| Describe current guideline-recommended lipid targets and risk stratification strategies for patients with dyslipidemia.

2| Review stepwise treatment algorithms for the management of dyslipidemia based on patient-specific cardiovascular risk.

3| Compare mechanisms of action, efficacy, and clinical roles of available lipid-lowering therapies.

4| Apply guideline-directed treatment strategies to optimize pharmacologic management of dyslipidemia in clinical practice.

Presenter(s): 
Brittney Brzoska, PharmD
PGY2 Ambulatory Care Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Brittney Brzoska, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
03/16/2026 - 2:00pm to 3:00pm EDT
Location: 
Hybrid
United States
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.